SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-013283
Filing Date
2021-02-08
Accepted
2021-02-08 07:01:13
Documents
23
Period of Report
2021-02-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm215482d1_8k.htm 8-K 22979
2 EXHIBIT 99.1 tm215482d1_ex99-1.htm EX-99.1 38587
3 GRAPHIC image_001.jpg GRAPHIC 706175
4 GRAPHIC image_002.jpg GRAPHIC 566693
5 GRAPHIC image_003.jpg GRAPHIC 405119
6 GRAPHIC image_004.jpg GRAPHIC 321464
7 GRAPHIC image_005.jpg GRAPHIC 199482
8 GRAPHIC image_006.jpg GRAPHIC 452063
9 GRAPHIC image_007.jpg GRAPHIC 412933
10 GRAPHIC image_008.jpg GRAPHIC 456161
11 GRAPHIC image_009.jpg GRAPHIC 224532
12 GRAPHIC image_010.jpg GRAPHIC 390778
13 GRAPHIC image_011.jpg GRAPHIC 292666
14 GRAPHIC image_012.jpg GRAPHIC 278688
15 GRAPHIC image_013.jpg GRAPHIC 403367
16 GRAPHIC image_014.jpg GRAPHIC 271864
17 GRAPHIC image_015.jpg GRAPHIC 280613
18 GRAPHIC image_016.jpg GRAPHIC 358712
19 GRAPHIC image_017.jpg GRAPHIC 464517
20 GRAPHIC image_018.jpg GRAPHIC 786930
21 GRAPHIC image_019.jpg GRAPHIC 617516
22 GRAPHIC image_020.jpg GRAPHIC 675575
23 GRAPHIC image_021.jpg GRAPHIC 547714
  Complete submission text file 0001104659-21-013283.txt   12601858
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39676 | Film No.: 21598507
SIC: 2836 Biological Products, (No Diagnostic Substances)